Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria

Background: Published appropriate use criteria (AUC) describe patients for whom amyloid positron emission tomography (PET) might be most useful. This study compared the impact of amyloid PET on diagnosis and management in subjects likely to either meet or not meet AUC. Methods: Physicians provided a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Dementia and geriatric cognitive disorders 2016-01, Vol.41 (1-2), p.80-92
Hauptverfasser:	Grundman, Michael, Johnson, Keith A., Lu, Ming, Siderowf, Andrew, Dell''Agnello, Grazia, Arora, Anupa K., Skovronsky, Daniel M., Mintun, Mark A., Pontecorvo, Michael J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Alzheimer Disease - diagnosis Alzheimer Disease - drug therapy Alzheimer's disease Amyloid - analysis Amyloid beta-Peptides - analysis Aniline Compounds Brain - diagnostic imaging Care and treatment Cognition Cognitive Dysfunction - diagnosis Cognitive Dysfunction - drug therapy Comparative analysis Diagnosis Diagnostic imaging Ethylene Glycols Female Florbetapir Flutemetamol Humans Male Neuropsychological Tests Original Research Article Physicians Positron emission tomography Radiopharmaceuticals Tomography
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!